by Halia Therapeutics | Oct 18, 2023 | Press Releases
LEHI, Utah, Oct. 18, 2023 /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical company advancing innovative medicines to treat a broad range of diseases driven by chronic inflammation and neurodegeneration, today announced that Jared Bearss,... 
by Halia Therapeutics | Sep 19, 2023 | News & Media
“David Bearss’ passion for drug discovery has guided his noteworthy career as a dynamic leader who integrates scientific and business interests to deliver new medicines to patients. That passion is still evident today as he gives back to the industry he loves,... 
by Halia Therapeutics | Sep 18, 2023 | News & Media
“Halia Therapeutics believes it is on the forefront of research to target chronic inflammation to treat neurodegeneration and inflammatory diseases. Chronic inflammation causes more health issues than the average person may realize. It causes arthritis, anemia,... by Halia Therapeutics | Aug 31, 2023 | Press Releases
SALT LAKE CITY, Aug. 31, 2023 /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical company advancing innovative medicines to treat a broad range of diseases driven by chronic inflammation and neurodegeneration, today announced they... by Halia Therapeutics | Aug 23, 2023 | News & Media
Thanks to Salt Lake City’s FOX 13 News for attending and reporting on Halia Therapeutics’ grand opening. This report aired August 23,...